Abigél Margit Kolonics-Farkas

Long-Term Effects and Adverse Events of Nintedanib Therapy in Idiopathic Pulmonary Fibrosis Patients with Functionally Advanced Disease

Enikő Bárczi, Livia Starobinski, Abigél Margit Kolonics-Farkas et al. · Advances in Therapy · 2019 · 26 citations

Nintedanib Therapy, Adverse Events, Antifibrotic Therapy +6

Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival

Enikő Bárczi, Tamás Nagy, Livia Starobinski et al. · Thoracic Cancer · 2020 · 23 citations · Full text

Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE

Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç et al. · Drug Safety · 2020 · 20 citations · Full text

Autoimmune Progressive Fibrosing Interstitial Lung Disease: Predictors of Fast Decline

Alexandra Nagy, Tamás Nagy, Abigél Margit Kolonics-Farkas et al. · Frontiers in Pharmacology · 2021 · 18 citations · Full text

Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries

Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç et al. · Frontiers in Medicine · 2021 · 14 citations · Full text